Progressive Multifocal Leukoencephalopathy: Current Insights

Cases of PML should be evaluated according to predisposing factors, as these subgroups differ by incidence rate, clinical course, and prognosis. The three most significant groups at risk of PML are patients with hematological malignancies mostly previously treated with immunotherapies but also untre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kartau, Marge, Sipilä, Jussi OT, Auvinen, Eeva, Palomäki, Maarit, Verkkoniemi-Ahola, Auli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896915/
https://www.ncbi.nlm.nih.gov/pubmed/31819703
http://dx.doi.org/10.2147/DNND.S203405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896915/
https://www.ncbi.nlm.nih.gov/pubmed/31819703
http://dx.doi.org/10.2147/DNND.S203405

Ejemplares similares